HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Amyotrophic Lateral Sclerosis 5

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Cognitive Dysfunction
2.	Frontotemporal Dementia (Semantic Dementia)
3.	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
4.	Parkinson Disease (Parkinson's Disease)
5.	Dementia (Dementias)

Experts

1.	Alquézar, Carolina: 1 article (11/2013)
2.	Bermejo-Pareja, Félix: 1 article (11/2013)
3.	Esteras, Noemí: 1 article (11/2013)
4.	Martín-Requero, Angeles: 1 article (11/2013)
5.	Villarejo, Alberto: 1 article (11/2013)
6.	de la Encarnación, Ana: 1 article (11/2013)
7.	Cox, P R: 1 article (01/2001)
8.	Siddique, T: 1 article (01/2001)
9.	Zoghbi, H Y: 1 article (01/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Amyotrophic Lateral Sclerosis 5:

1.	ProgranulinsIBA 11/07/2013 - "A total of 165 subjects were enrolled in the study, including 56 AD patients, 15 patients with mild cognitive impairment, 7 with frontotemporal dementia associated with progranulin mutations, 4 with dementia with Lewy bodies, 20 patients with Parkinson's disease, 10 with amyotrophic lateral sclerosis, 5 with progressive supranuclear palsy, and 48 cognitively normal individuals. "
2.	TropomodulinIBA 01/01/2001 - "We had previously mapped Tropomodulin 2 (TMOD2) to the genomic region containing the gene for amyotrophic lateral sclerosis 5 (ALS5). "